NCT00889915
Comparing the Effectiveness of New Versus Older Treatments for Attention Deficit Hyperactivity Disorder (The NOTA Study)
See it on ClinicalTrials.gov ↗228 people
31.6%
68.4%
72 womenmiddle line = equal numbers156 men
- Phase
- PHASE4
- Paid for by
- Duke University
- Finished
- 2009-12
- Health conditions
- Attention Deficit Disorder With Hyperactivity
- Who could join
- Anyone
- Ages
- 6 Years – 17 Years
- Average age
- mean 10.3 years
- Age 65+
- 0%
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- Age limit under 65
Older women were turned away, even though they often take this medicine.
“Maximum age: 17 Years.”
- No pregnant women
Women who were pregnant could not join.
“Pregnant or positive result of pregnancy test”
- No seizures
Women with epilepsy or past seizures were turned away.
“…of other clinically significant medical conditions, including hyperthyroidism, epilepsy or other seizure disorder, any condition for which an increase in blood pressure or heart rate would be problematic, glaucoma or other significant eye…”
- No mental health conditions
Women with depression, bipolar disorder or other mental health conditions were turned away.
“Currently taking another medication for ADHD, including another psychostimulant, atomoxetine, or bupropion”
Study titles and rules are shown in their original English.